MwanzoPHIO • NASDAQ
add
Phio Pharmaceuticals Corp
$ 1.12
Baada ya Saa za Kazi:(0.89%)+0.0100
$ 1.13
Imefungwa: 12 Des, 19:21:13 GMT -5 · USD · NASDAQ · Kanusho
Bei iliyotangulia
$ 1.14
Bei za siku
$ 1.12 - $ 1.17
Bei za mwaka
$ 0.97 - $ 9.79
Thamani ya kampuni katika soko
12.06M USD
Wastani wa hisa zilizouzwa
6.00M
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | — | — |
Matumizi ya uendeshaji wa biashara | 1.32M | 39.96% |
Mapato halisi | -2.39M | -56.96% |
Kiwango cha faida halisi | — | — |
Mapato kwa kila hisa | -0.44 | — |
EBITDA | -2.50M | -57.51% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 10.70M | 98.61% |
Jumla ya mali | 11.50M | 96.16% |
Jumla ya dhima | 1.67M | 81.28% |
Jumla ya hisa | 9.84M | — |
hisa zilizosalia | 10.76M | — |
Uwiano wa bei na thamani | 0.67 | — |
Faida inayotokana na mali | -54.92% | — |
Faida inayotokana mtaji | -62.83% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -2.39M | -56.96% |
Pesa kutokana na shughuli | -2.08M | -6.76% |
Pesa kutokana na uwekezaji | elfu -7.00 | — |
Pesa kutokana na ufadhili | 2.02M | -23.55% |
Mabadiliko halisi ya pesa taslimu | elfu -70.00 | -110.12% |
Mtiririko huru wa pesa | -1.27M | 11.16% |
Kuhusu
Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Wikipedia
Ilianzishwa
2011
Tovuti
Wafanyakazi
5
